Back to Search
Start Over
Vaccines and Allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
- Source :
- ALLERGY, r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, instname, Sampath, V, Rabinowitz, G, Shah, M, Jain, S, Diamant, Z, Jesenak, M, Rabin, R, Vieths, S, Agache, I, Akdis, M, Barber, D, Breiteneder, H, Chinthrajah, S, Chivato, T, Collins, W, Eiwegger, T, Fast, K, Fokkens, W, O'Hehir, R E, Ollert, M, O'Mahony, L, Palomares, O, Pfaar, O, Riggioni, C, Shamji, M H, Sokolowska, M, Jose Torres, M, Traidl-Hoffmann, C, van Zelm, M, Wang, D Y, Zhang, L, Akdis, C A & Nadeau, K C 2021, ' Vaccines and Allergic reactions : The past, the current COVID-19 pandemic, and future perspectives ', Allergy: European Journal of Allergy and Clinical Immunology, vol. 76, no. 6, pp. 1640-1660 . https://doi.org/10.1111/all.14840, Allergy, r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Fundació Sant Joan de Déu
- Publication Year :
- 2021
-
Abstract
- Vaccines are essential public health tools with a favorable safety profile and prophylactic effectiveness that have historically played significant roles in reducing infectious disease burden in populations, when the majority of individuals are vaccinated. The COVID-19 vaccines are expected to have similar positive impacts on health across the globe. While serious allergic reactions to vaccines are rare, their underlying mechanisms and implications for clinical management should be considered to provide individuals with the safest care possible. In this review, we provide an overview of different types of allergic adverse reactions that can potentially occur after vaccination and individual vaccine components capable of causing the allergic adverse reactions. We present the incidence of allergic adverse reactions during clinical studies and through post-authorization and post-marketing surveillance and provide plausible causes of these reactions based on potential allergenic components present in several common vaccines. Additionally, we review implications for individual diagnosis and management and vaccine manufacturing overall. Finally, we suggest areas for future research.
- Subjects :
- 0301 basic medicine
Allergy
CHILDREN
Review Article
HYPERSENSITIVITY REACTIONS
SARS‐CoV‐2
0302 clinical medicine
allergy
vaccine
Pandemic
Immunology and Allergy
PROTEIN-COUPLED RECEPTOR-X2
Review Articles
anaphylaxis
Vaccines
SARS-CoV-2
Vaccination
Safety profile
VACCINATION
COVID-19
Anaphylaxis
medicine.medical_specialty
COVID-19 Vaccines
Coronavirus disease 2019 (COVID-19)
Hypersensitivity/diagnosis
Immunology
03 medical and health sciences
COVID‐19
medicine
Hypersensitivity
Vaccines/adverse effects
Humans
MAST-CELL
Intensive care medicine
Pandemics
business.industry
Public health
GELATIN
ANTI-PEG ANTIBODIES
medicine.disease
030104 developmental biology
030228 respiratory system
Infectious disease (medical specialty)
ADVERSE-REACTIONS
SAFETY DATA
business
Subjects
Details
- Language :
- English
- ISSN :
- 01054538
- Volume :
- 76
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Allergy: European Journal of Allergy and Clinical Immunology
- Accession number :
- edsair.doi.dedup.....348181fc4abf32ff209019c846047a90